logo
This Drink May Lower Your Dementia Risk by 25%, New Study Says

This Drink May Lower Your Dementia Risk by 25%, New Study Says

Yahoo30-06-2025
Reviewed by Dietitian Emily Lachtrupp, M.S., RDGreen tea may have more beneficial plant compounds for dementia than other teas.
Drinking 2.5 cups of green tea per day was associated with a 25% reduced risk of dementia.
Other foods with the same antioxidants as green tea include dark chocolate and berries.Brain health has become a popular topic as scientists continue to study the brain in more depth. And while there is still much to learn about the brain, one thing we do know is that dementia is on the rise. We recently reported on a study that suggests that new dementia cases may double from half a million to a million per year by the year 2060. Since we know more about the brain and how to take care of it than we did just a few years ago, this estimation is pretty astonishing.
Dementia is a general term for a loss of memory, language, problem-solving skills and other abilities that are severe enough to interfere with everyday life. Alzheimer's disease is the most common type of dementia.
We know that nutrition plays a large role in brain health. There's even a diet designed specifically to provide brain-healthy nutrients, called the MIND diet. Scientists also consider specific foods to see if there is any correlation between them and decreased disease risk. This is what researchers from Japan did regarding green tea and dementia risk. They recently published their findings in The Journal of Nutrition, Health and Aging. Let's break down what they found.
Researchers drew data from a long-running Japanese study called the Murakami study. This study included 13,660 people, about 52% women with an average age of 59.
Some of the demographics adjusted for during statistical analysis included sex, age, BMI, physical activity, smoking status, alcohol consumption, education level, marital status and medical history. Participants also filled out food frequency questionnaires asking how much and how often certain foods and beverages were consumed, including tea and coffee. Baseline data was collected between 2011 and 2013, and the average follow-up time for each participant was 11.5 years.
For tea and coffee, participants were given the following options for their intake: <1 cup per week, 1-2 cups per week, 3-4 cups per week, 5-6 cups per week, 1 cup per day, 2-3 cups per day, 4-6 cups per day, 7-9 cups per day, and 10 cups per day. Options were also given for canned and bottled tea and coffee, and amounts were calculated into the total intake.
It's important to note that 'a cup' can be interpreted as different amounts in studies and, in this case, is not equal to our American-sized measuring cup. For this reason, researchers calculated consumption into milliliters per day and then placed participants into one of four quartiles (categories). Q1 drank <94 mL of green tea per day, Q2 drank 94-299 mL/day, Q3 drank 300-599 mL/day and Q4 drank ≥ 600 mL/day.
Because they were looking specifically for associations between tea and dementia risk, researchers also gathered data regarding dementia from Japan's long-term care insurance (LTCI) database. In the LTCI, physicians assess the degree of dementia and classify patients into six ranks ranging from no dementia (0) to severe dementia-related behavioral impairment and cognitive impairment requiring treatment (V)—basically using Roman numerals, plus the number 0. Those with rank II (moderate dementia-related behavioral disturbances and cognitive dysfunction with mild dependence) or higher are considered to have dementia.
After running statistical analyses, researchers found that those in the higher quartiles for green tea intake had a lower risk of dementia. Specifically, those in the highest quartile, who drank at least 600 mL (or 20 fluid ounces) per day, had a 25% lower risk of dementia compared to those in the first quartile.
They also broke it down by cups of green tea consumed. Participants saw about a 5% reduction in dementia risk for each cup increase in green tea. For example, if someone averaged a cup of green tea a day, they may decrease their risk of dementia by 5%. For someone who drinks 2 cups a day, the reduction in risk goes to 10%. Keep in mind, though, that these cups are not what we consider a measuring cup amount—they're actually closer to about ½ cup. As an example, Q4 drank at least 600 mL of green tea a day, which is equal to about 2.5 American measuring cups, and reduced their risk of dementia by 25% compared to those in Q1.
Because there is some evidence that coffee may decrease dementia risk, researchers were curious to know if those who drank both coffee and green tea might lower their risk even more. Turns out, unlike those who drank a lot of green tea, adding high levels of coffee in addition to green tea did not have the same effects as green tea alone, and showed no reduction in dementia risk.
Researchers propose a couple of possible reasons for this. First, drinking both green tea and coffee in high doses might have a sort of overdose effect, especially regarding caffeine. As an example, green tea contains 20 mg of caffeine per 100 mL dose, and coffee contains 60 mg of caffeine for the same amount. During the combined portion of this trial, participants in Q4 consumed at least 600 mL/day of green tea and 300 mL/day of coffee, which averages out to 300 mg of caffeine per day. And some were drinking well beyond these amounts. The current recommendation for caffeine is no more than 400 mg/day, so those in Q4 were definitely near or beyond that amount.
Researchers also note that coffee and tea contain different plant compounds and that they may counteract each other. But they seemed to lean more into the caffeine theory.
There are a few limitations to this study. One is that participants' cognitive status was not assessed at baseline. So there's a chance that those who had lower cognitive function at the start of the study drank less green tea. If this is true, then the association between green tea and reduced risk of dementia would be weaker. Also, because green tea consumption was estimated based on self-reports, it leaves room for bias and inaccuracies. Lastly, the type of dementia wasn't investigated, so they can't say which types of dementia green tea may reduce. Researchers do note, however, that because it's estimated that Alzheimer's disease makes up about two-thirds of dementia cases, green tea may help reduce the risk of Alzheimer's.
All types of true teas—green, black, white and oolong—are loaded with antioxidants. They are, after all, plants, and all plants contain antioxidants. But compared to the others, green tea has been shown to have the highest levels of catechins, a specific type of flavonoid antioxidant, providing about four times more catechins than black tea. One of these catechins is epigallocatechin3-gallate (EGCG), which researchers note in previous studies has been linked to reduced Alzheimer's risk. Reasons for this may be due to EGCG's ability to reduce inflammation, including in the brain, plus reduce amyloid-beta and tau-tangle accumulation, both of which are implicated in Alzheimer's disease.
That's not to say that other teas don't have their own benefits. For example, black tea may help you live longer, and ginger tea can help ease an upset stomach and reduce arthritis pain. Mint tea has been shown to have digestive, respiratory and mental health benefits, as well as antimicrobial and antiviral properties.
Besides brain health, green tea has also been associated with lower inflammation, better digestion, less bloating, improved blood sugar and cholesterol levels, and reduced risk of cancer.
It's easy to add green tea to your life. Simply brew up a cup. Ideally, we recommend using loose-leaf tea and steeping it in a tea strainer. The reason for this is that some tea bags have been shown to contain microplastics. These tiny particles may end up steeping from the bag into your cup of tea and ultimately into your body, including your brain. If you're looking to limit your microplastic exposure, a tea strainer may be the best steeping option.
Plain green tea is best, but adding a small amount of honey or sugar or a touch of milk is fine if that's how you prefer it. Just be mindful of how much you add, since too much added sugar has been associated with worse brain health, including dementia. If you want to get to zero additions in your tea, take your usual amount of sweetener and/or cream and begin reducing that amount each week until you're at nothing but the tea. Doing this gradually will help your taste buds adjust. It's also important to point out that the longer you steep your tea, the more bitter it's likely to become. If you don't care for the bitterness, go with shorter steeping times.
If you're not a tea drinker (and even if you are) and want the benefits of catechins, there are a few options for you. Dark chocolate, cherries and berries, including blackberries, raspberries and strawberries, are rich in these powerful plant compounds. Dark chocolate and walnuts make a great brain-healthy snack. And cherries and berries are amazing in smoothies, including our Cherry-Mocha Smoothie, Raspberry-Kefir Power Smoothie and our Berry-Green Tea Smoothie, which provides catechins from both berries and green tea.
If you're ready to really dive into eating for brain health, then you'll want to try our 30-Day MIND Diet Meal Plan for Cognitive Health or our Simple 7-Day Cognitive Health Meal Plan.
This study suggests that higher consumption of green tea is associated with reduced risk of dementia, compared to those with little to no green tea intake. Other lifestyle habits also contribute to brain health, including overall diet, physical activity, managing stressors and getting plenty of quality sleep. If this feels overwhelming and you're not sure where to start, choose an area you're likely to have success in. Adding a couple of cups of green tea each day could be an easy addition and starting point.
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Carolyn Hax: Without explanation, sister-in-law no-shows care for dying mom
Carolyn Hax: Without explanation, sister-in-law no-shows care for dying mom

Washington Post

timean hour ago

  • Washington Post

Carolyn Hax: Without explanation, sister-in-law no-shows care for dying mom

Adapted from an online discussion. Dear Carolyn: My sister-in-law, Meg, and I have been close from Day 1. We've raised our kids together and supported each other through life's lows and highs. When my father-in-law, her dad, was diagnosed with dementia, we were a natural team — plus my husband, of course — supporting my mother-in-law. But when my mother-in-law was diagnosed with cancer, Meg just disappeared. She made herself scarce emotionally and physically. Everything was left to me and my husband.

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

Yahoo

time2 hours ago

  • Yahoo

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPD Additional 11 programmes to be developed by Hengrui Pharma and optioned by GSK following phase I completion JIANGSU, China, July 27, 2025 /PRNewswire/ -- Hengrui Pharma ( today announced it has entered into agreements with GSK plc (LSE/NYSE: GSK) to develop up to 12 innovative medicines, adding significant value to the globalization strategy of Hengrui and significant new growth opportunities to GSK beyond 2031. The programmes were selected to complement GSK's extensive Respiratory, Immunology & Inflammation (RI&I) and Oncology pipeline, and assessed for their potential best- or first-in-class profiles. GSK will pay $500 million in upfront fees across the agreements. The agreements include an exclusive worldwide license (excluding mainland China, Hong Kong SAR, Macau SAR and Taiwan region) for a potential best-in-class, PDE3/4 inhibitor (HRS-9821) in clinical development for the treatment of chronic obstructive pulmonary disease (COPD) as an add-on maintenance treatment, irrespective of background therapy. The addition of HRS-9821 supports GSK's ambition to treat patients across the widest spectrum of COPD by including those who face continued dyspnoea (shortness of breath) or who are unlikely to receive inhaled corticosteroids or biologics, based on their disease profile. HRS-9821 has demonstrated potent PDE3 and PDE4 inhibition, leading to increased bronchodilation and anti-inflammatory effects in early clinical and preclinical studies. In addition, HRS-9821 provides the opportunity for a convenient dry-powder inhaler (DPI) formulation that strategically fits GSK's established inhaled portfolio. The agreements also include a pioneering scaled collaboration to generate up to 11 programmes in addition to HRS-9821, each with its own financial structure. Hengrui Pharma will lead the development of these programmes up to completion of phase I trials, including patients outside of China. GSK will have the exclusive option to further develop and commercialise each programme worldwide (excluding mainland China, Hong Kong SAR, Macau SAR and Taiwan region), at the end of phase I or earlier at GSK's election as well as certain programme substitution rights. Frank Jiang, Executive Vice President and Chief Strategy Officer of Hengrui Pharma, said: "This strategic collaboration with GSK marks yet another significant milestone in Hengrui's globalisation journey and our mission to innovate and deliver higher-quality, cutting-edge therapies for patients worldwide. GSK brings additional R&D expertise, a robust global clinical network, and broad regulatory capabilities that will accelerate our PDE3/4 inhibitor as well as an array of other innovative therapy programs to overseas markets, potentially delivering breakthrough treatments to patients globally." Tony Wood, Chief Scientific Officer, GSK said: "We're delighted to announce these exciting agreements with Hengrui Pharma which complement our already-extensive pipeline. This deal reflects our strategic investment in programmes that address validated targets, increasing the likelihood of success, and with the option to advance those assets with the greatest potential for patient impact." The collaboration enables scale and speed to proof-of-concept to develop up to 11 additional innovative medicines. It benefits from GSK's therapy area expertise, deep understanding of disease biology, clinical development capability and global commercial scale with Hengrui Pharma's early discovery engine, platform technologies, extensive pre-clinical pipeline of high-value programmes and speed of clinical evaluation. Financial considerations GSK will pay $500 million in upfront fees across the agreements including for the license of the PDE3/4 programme. The potential total value of future success-based development, regulatory and commercial milestone payments to Hengrui Pharma is approximately $12 billion if all programmes are optioned and all milestones are achieved. In addition, Hengrui Pharma will be eligible to receive tiered royalties on global product net sales (excluding mainland China, Hong Kong SAR, Macau SAR and Taiwan region). The license to HRS-9821 is subject to customary conditions, including applicable regulatory agency clearances under the Hart-Scott-Rodino Act in the US. About GSKGSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at About Hengrui PharmaHengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialisation of high-quality medicines to address unmet clinical needs. With a global R&D team that includes 14 R&D centres and more than 5,500 professionals, Hengrui Pharma's therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. To date, Hengrui has commercialised 23 new molecular entity drugs and 4 other innovative drugs in China. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology. Media on behalf of Hengrui Pharma:DGA Grouphengrui@ View original content: SOURCE Jiangsu Hengrui Pharmaceuticals Co., Ltd Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

SM Lee: Electing more opposition MPs to check Govt is 'wrong direction'; More teen births in 2024, gradual increase from 2022: Singapore live news
SM Lee: Electing more opposition MPs to check Govt is 'wrong direction'; More teen births in 2024, gradual increase from 2022: Singapore live news

Yahoo

time3 hours ago

  • Yahoo

SM Lee: Electing more opposition MPs to check Govt is 'wrong direction'; More teen births in 2024, gradual increase from 2022: Singapore live news

Senior Minister Lee Hsien Loong acknowledged on 26 July that the opposition is now a permanent feature of Singapore politics. He said the growing number of opposition Members of Parliament (MP) reflects a growing public desire for alternative voices in Parliament, a sentiment he described as "quite natural" and "quite understandable." He cautioned that this shift could lower the quality of governance and jeopardise Singapore's future. SM Lee said, "You can elect more opposition MPs to check the Government... but once you are set on that path, you are heading in the wrong direction." More teenagers in Singapore are becoming mothers, marking a reversal of a steady decline in teen births in the past 20 years, according to the Report on Registration of Births and Deaths 2024 released by the Immigration and Checkpoints Authority. In 2024, 244 babies were born to teens aged 19 or younger, up 7 per cent from 228 in 2023. There were 218 teen births in 2022. The Health Ministry also noted that in the past five years, the average age of pregnant teens was 18. Read more in our live blog below, including the latest local and international news and updates. More teen births in 2024, gradual increase from 2022 More teenagers in Singapore are becoming mothers, marking a reversal of a steady decline in teen births in the past 20 years, according to the Report on Registration of Births and Deaths 2024 released by the Immigration and Checkpoints Authority. In 2024, 244 babies were born to teens aged 19 or younger, up 7 per cent from 228 in 2023. There were 218 teen births in 2022. The Health Ministry also noted that in the past five years, the average age of pregnant teens was 18. Ms Melisa Wong, executive director at Babes Pregnancy Crisis Support, cited multiple factors behind the rise. She said that during the Covid-19 pandemic, many teens felt isolated or struggled with other negative emotions, and some may have engaged in unprotected sex to seek connection or to cope with whatever they were going through. Ms Wong added that while teens are exploring relationships at younger age, some may not use contraceptives for various reasons. She also pointed out that part of the increase in teen births may also be due to a decline in abortions. For more on Singapore's teen pregnancy stats, read here. SM Lee: Electing more opposition MPs to check Govt is 'wrong direction' Senior Minister Lee Hsien Loong acknowledged on 26 July that the opposition is now a permanent feature of Singapore politics. He said the growing number of opposition Members of Parliament (MP) reflects a growing public desire for alternative voices in Parliament, a sentiment he described as "quite natural" and "quite understandable." Despite the rise in opposition presence, the ruling People's Action Party (PAP) must continue to perform well and earn voter support to ensure the country's continued success, he said at a National Day dinner in Serangoon. Following the 2025 General Election, the 15th Parliament will have 12 opposition MPs, including two Non-Constituency MPs – the same number as in the 2020 General Election. SM Lee stated, "The opposition is here to stay in Singapore politics. But in order for Singapore to keep on doing well, the Government has to continue to hold its own, and to win votes and to win seats in elections." If the ruling party weakens, it could become more difficult to form teams, govern well, and garner support for policies, he warned. He cautioned that this shift could lower the quality of governance and jeopardise Singapore's future. SM Lee said, "You can elect more opposition MPs to check the Government... but once you are set on that path, you are heading in the wrong direction." SM Lee urged called for striking the right balance between having stronger alternative voices in government, and supporting and electing an effective government that can make tough, long-term decisions in the nation's interest. He stressed that the country needs a capable government to maintain high standards and navigate challenges, especially given global uncertainties. SM Lee concluded by saying he was heartened that Singaporeans recognised the importance of strong leadership and had given the PAP a firm mandate in the May election, where it received 65.57 per cent of the popular vote – up from 61.24 per cent in 2020. For more on SM Lee's National Day dinner remarks, read here. More teen births in 2024, gradual increase from 2022 More teenagers in Singapore are becoming mothers, marking a reversal of a steady decline in teen births in the past 20 years, according to the Report on Registration of Births and Deaths 2024 released by the Immigration and Checkpoints Authority. In 2024, 244 babies were born to teens aged 19 or younger, up 7 per cent from 228 in 2023. There were 218 teen births in 2022. The Health Ministry also noted that in the past five years, the average age of pregnant teens was 18. Ms Melisa Wong, executive director at Babes Pregnancy Crisis Support, cited multiple factors behind the rise. She said that during the Covid-19 pandemic, many teens felt isolated or struggled with other negative emotions, and some may have engaged in unprotected sex to seek connection or to cope with whatever they were going through. Ms Wong added that while teens are exploring relationships at younger age, some may not use contraceptives for various reasons. She also pointed out that part of the increase in teen births may also be due to a decline in abortions. For more on Singapore's teen pregnancy stats, read here. More teenagers in Singapore are becoming mothers, marking a reversal of a steady decline in teen births in the past 20 years, according to the Report on Registration of Births and Deaths 2024 released by the Immigration and Checkpoints Authority. In 2024, 244 babies were born to teens aged 19 or younger, up 7 per cent from 228 in 2023. There were 218 teen births in 2022. The Health Ministry also noted that in the past five years, the average age of pregnant teens was 18. Ms Melisa Wong, executive director at Babes Pregnancy Crisis Support, cited multiple factors behind the rise. She said that during the Covid-19 pandemic, many teens felt isolated or struggled with other negative emotions, and some may have engaged in unprotected sex to seek connection or to cope with whatever they were going through. Ms Wong added that while teens are exploring relationships at younger age, some may not use contraceptives for various reasons. She also pointed out that part of the increase in teen births may also be due to a decline in abortions. For more on Singapore's teen pregnancy stats, read here. SM Lee: Electing more opposition MPs to check Govt is 'wrong direction' Senior Minister Lee Hsien Loong acknowledged on 26 July that the opposition is now a permanent feature of Singapore politics. He said the growing number of opposition Members of Parliament (MP) reflects a growing public desire for alternative voices in Parliament, a sentiment he described as "quite natural" and "quite understandable." Despite the rise in opposition presence, the ruling People's Action Party (PAP) must continue to perform well and earn voter support to ensure the country's continued success, he said at a National Day dinner in Serangoon. Following the 2025 General Election, the 15th Parliament will have 12 opposition MPs, including two Non-Constituency MPs – the same number as in the 2020 General Election. SM Lee stated, "The opposition is here to stay in Singapore politics. But in order for Singapore to keep on doing well, the Government has to continue to hold its own, and to win votes and to win seats in elections." If the ruling party weakens, it could become more difficult to form teams, govern well, and garner support for policies, he warned. He cautioned that this shift could lower the quality of governance and jeopardise Singapore's future. SM Lee said, "You can elect more opposition MPs to check the Government... but once you are set on that path, you are heading in the wrong direction." SM Lee urged called for striking the right balance between having stronger alternative voices in government, and supporting and electing an effective government that can make tough, long-term decisions in the nation's interest. He stressed that the country needs a capable government to maintain high standards and navigate challenges, especially given global uncertainties. SM Lee concluded by saying he was heartened that Singaporeans recognised the importance of strong leadership and had given the PAP a firm mandate in the May election, where it received 65.57 per cent of the popular vote – up from 61.24 per cent in 2020. For more on SM Lee's National Day dinner remarks, read here. Senior Minister Lee Hsien Loong acknowledged on 26 July that the opposition is now a permanent feature of Singapore politics. He said the growing number of opposition Members of Parliament (MP) reflects a growing public desire for alternative voices in Parliament, a sentiment he described as "quite natural" and "quite understandable." Despite the rise in opposition presence, the ruling People's Action Party (PAP) must continue to perform well and earn voter support to ensure the country's continued success, he said at a National Day dinner in Serangoon. Following the 2025 General Election, the 15th Parliament will have 12 opposition MPs, including two Non-Constituency MPs – the same number as in the 2020 General Election. SM Lee stated, "The opposition is here to stay in Singapore politics. But in order for Singapore to keep on doing well, the Government has to continue to hold its own, and to win votes and to win seats in elections." If the ruling party weakens, it could become more difficult to form teams, govern well, and garner support for policies, he warned. He cautioned that this shift could lower the quality of governance and jeopardise Singapore's future. SM Lee said, "You can elect more opposition MPs to check the Government... but once you are set on that path, you are heading in the wrong direction." SM Lee urged called for striking the right balance between having stronger alternative voices in government, and supporting and electing an effective government that can make tough, long-term decisions in the nation's interest. He stressed that the country needs a capable government to maintain high standards and navigate challenges, especially given global uncertainties. SM Lee concluded by saying he was heartened that Singaporeans recognised the importance of strong leadership and had given the PAP a firm mandate in the May election, where it received 65.57 per cent of the popular vote – up from 61.24 per cent in 2020. For more on SM Lee's National Day dinner remarks, read here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store